Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders
Bahareh Peyrovian, Joshua D. Rosenblat, Zihang Pan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 92, pp. 387-404
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 96
Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy (Review)
I.D. Rădulescu, Ana Miruna Drăgoi, Simona Trifu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 68
Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101838-101838
Closed Access | Times Cited: 23
An update on NMDA antagonists in depression
Bartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 11, pp. 1055-1067
Closed Access | Times Cited: 54
d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders
Herman Wolosker, Darrick T. Balu
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 54
The Role of D-Amino Acids in Alzheimer’s Disease
Luciano Piubelli, Giulia Murtas, Valentina Rabattoni, et al.
Journal of Alzheimer s Disease (2021) Vol. 80, Iss. 2, pp. 475-492
Closed Access | Times Cited: 43
Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors
Dolores Piniella, Francisco Zafra
Neuropharmacology (2023) Vol. 232, pp. 109514-109514
Open Access | Times Cited: 19
d-Alanine: Distribution, origin, physiological relevance, and implications in disease
Cindy J. Lee, Tian Qiu, Jonathan V. Sweedler
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020) Vol. 1868, Iss. 11, pp. 140482-140482
Closed Access | Times Cited: 48
Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
Chun-Hung Chang, Chieh‐Hsin Lin, Chieh‐Yu Liu, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 5, pp. 495-505
Closed Access | Times Cited: 35
Machine-learning-based diagnosis of drug-naive adult patients with attention-deficit hyperactivity disorder using mismatch negativity
Sungkean Kim, Ji Hyun Baek, Young‐Joon Kwon, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
Ruri Okubo, Motohiro Okada, Eishi Motomura
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1128-1128
Open Access | Times Cited: 4
An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine
Domenico De Berardis, Carmine Tomasetti, Maurizio Pompili, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 7, pp. 554-584
Closed Access | Times Cited: 28
Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential
Chloé Geoffroy, Pierre Paoletti, Laétitia Mony
The Journal of Physiology (2021) Vol. 600, Iss. 2, pp. 233-259
Open Access | Times Cited: 25
Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties
Chih‐Chia Huang, I‐Hua Wei, Huiting Yang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 7, pp. 2066-2076
Closed Access | Times Cited: 8
Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression
Jan Nowacki, Katja Wingenfeld, Michael Kaczmarczyk, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
GluN2D NMDA Receptors Gate Fear Extinction Learning and Interneuron Plasticity
C. Dubois, Siqiong June Liu
Frontiers in Synaptic Neuroscience (2021) Vol. 13
Open Access | Times Cited: 20
Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
Yue Du, Jinxue Wei, Zijian Zhang, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 19
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Yuriy M. Kositsyn, Murilo S. de Abreu, Tatiana O. Kolesnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9482-9482
Open Access | Times Cited: 7
Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
Xiaoli Sun, Lina Ma, Zhenzhu Chen, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 7
Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?
Joshua D. Manduca, Rachel-Karson Thériault, Melissa L. Perreault
Pharmacological Research (2020) Vol. 157, pp. 104819-104819
Closed Access | Times Cited: 20
Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment
Bernard J. Crespi
Evolution Medicine and Public Health (2019) Vol. 2019, Iss. 1, pp. 149-168
Open Access | Times Cited: 19
Proteomic analysis of the intestine reveals SNARE-mediated immunoregulatory and amino acid absorption perturbations in a rat model of depression
Xue Gong, Cheng Huang, Xun Yang, et al.
Life Sciences (2019) Vol. 234, pp. 116778-116778
Closed Access | Times Cited: 17
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia
Andrea de Bartolomeis, Camilla Avagliano, Licia Vellucci, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 795-827
Closed Access | Times Cited: 17
Whole-brain irradiation differentially modifies neurotransmitters levels and receptors in the hypothalamus and the prefrontal cortex
Javier Franco‐Pérez, Sergio Montes, Josué Sánchez-Hernández, et al.
Radiation Oncology (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Simultaneous measurement of amino acid enantiomers in the serum of late-life depression patients using convenient LC–MS/MS method with Nα-(5-fluoro-2,4-dinitrophenyl)-l-leucinamide Derivatization
Mingxia Liu, Jing He, Can‐Jun Ruan, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 230, pp. 115387-115387
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top